This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Synbio_Tech Launches SYNMUE™ Probiotic
Business product launch

Synbio_Tech Launches SYNMUE™ Probiotic

Analysis based on 6 articles · First reported Jun 05, 2026 · Last updated Jun 05, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The launch of SYNMUE™ by Synbio Technologies is expected to positively impact the company's market position in the healthy aging and immune health supplements sectors. This innovation addresses a growing market demand, as highlighted by United Nations' population forecasts, potentially leading to increased revenue and market share for Synbio Technologies.

Biotechnology Pharmaceuticals Nutritional Supplements
Event Summary

Synbio Technologies, a biotechnology company, announced the launch of SYNMUE™, a new probiotic product designed to combat immune aging (immunosenescence). This product, featuring Lactiplantibacillus plantarum LP28, is backed by a human clinical study showing up to a 48% increase in Natural Killer (NK) cell activity in adults aged 50-75. SYNMUE™ aims to address the growing global demand for healthy aging solutions, with the immune health supplements market projected to exceed USD 76 billion by 2033. Synbio Technologies will showcase SYNMUE™ at Probiota Americas 2026 in Canada — Vancouver Island, Canada, alongside its other flagship ingredient, TWK10, which focuses on muscle resilience. Sean Yang, COO of Synbio Technologies, emphasized the importance of both immune and muscle resilience for extending healthspan. Hsiao-Wen Huang, a Senior Scientist at Synbio Technologies, will also present on microbiome modulation at the event.

Entities Involved
priv
Synbio Technologies
Synbio Technologies launched SYNMUE™, a new probiotic product targeting immune aging, and will showcase it at Probiota Americas 2026, expanding its healthy aging portfolio and market presence.
Importance 100.0 Sentiment 75.0
per
Sean Yang
Sean Yang, COO of Synbio Technologies, provided statements regarding the development and market positioning of SYNMUE™ and the company's broader healthy aging strategy.
Importance 70.0 Sentiment 60.0
oth
Probiota Americas
Probiota Americas 2026 is the event where Synbio Technologies will showcase its new product SYNMUE™ and other healthy aging innovations, facilitating meetings with potential partners.
Importance 60.0 Sentiment 50.0
per
Hsiao-Wen Huang
Hsiao-Wen Huang, Senior Scientist at Synbio Technologies, will present on microbiome modulation and its impact on muscle health, highlighting TWK10 at Probiota Americas 2026.
Importance 50.0 Sentiment 60.0
alliance
United Nations
The United Nations' forecasts on the aging global population are cited to highlight the growing demand for healthy aging solutions, providing market context for SYNMUE™.
Importance 20.0 Sentiment 0.0
loc
Canada — Vancouver Island
Canada — Vancouver Island, Canada, is the location where Probiota Americas 2026 will take place, serving as the venue for Synbio Technologies's product showcase.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.